Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2006

Jul 27, 2006

29777_dirs_2006-07-27_132dd903-89e5-4a02-8123-508fc37b7404.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-07-25

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-07-25 Common shares without par value M 4073 $41.9715 Acquired 224816 Direct
2006-07-25 Common shares without par value M 2355 $42.4226 Acquired 227171 Direct
2006-07-25 Common shares without par value F 5984 $47.56 Disposed 221187 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-07-25 Option (right to buy) $41.9715 M 4073 Disposed 2007-02-13 common shares (4.073) Direct
2006-07-25 Option (right to buy) $42.4226 M 2355 Disposed 2007-02-13 common shares (2355) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 466 Indirect
Common shares without par value 466 Indirect
Common shares without par value 466 Indirect
Common shares without par value 18578 Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of July 25, 2006.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.